Polio Eradication Program


Reporting Organization:WHO - World Health Organization
Total Budget ($CAD):$ 18,000,000
Timeframe: December 24, 2012 - March 30, 2015
Status: Completion
Contact Information: Unspecified

Partner & Funder Profiles


Reporting Organization


WHO - World Health Organization

Participating Organizations


Funders (Total Budget Contribution)


Return to top

Location


Country - Total Budget Allocation


Nigeria - $ 18,000,000.00 (100.00%)

Return to top

Areas of Focus


Health - Total Budget Allocation


Infectious & Communicable Diseases (100 %)

Return to top

Description


The goal of this project is to establish a more effective system for providing vaccinations in Nigeria and to increase the number of children under five who receive the polio vaccine. Nigeria is one of three countries in the world where children can still contract polio. Children under the age of five are the most at risk for polio infections and the risk is highest in northern Nigeria. It is estimated that 600,000 Nigerian children under five have never received a single dose of the polio vaccine. This project contributes to increasing the percentage of children under five who receive a full complement of vaccinations, including the polio vaccine, from 23% to 85% by 2015. This project supports the polio immunization activities of the Global Polio Eradication Initiative in Nigeria. Polio vaccination campaigns occur regularly throughout Nigeria both at the national level and at the state level, in areas where there is a higher rate of polio infections. The polio vaccination campaigns are also used as a platform for delivering other essential health services, such as routine vaccinations against common preventable diseases and health education. In addition, the project works with political, traditional, and religious leaders in Nigeria to build momentum toward greater community acceptance of polio immunization. The WHO is responsible for technical assistance, training, post-immunization campaign assessment surveys, data analysis, and report writing. The WHO also coordinates research, provides technical and operational support to the Federal and State Ministries of Health, and coordinates the training and deployment of human resources.

Return to top

Target Population


Gender and age: Under-5 children
Total Direct Population: Unspecified
Return to top

Outputs


Unspecified

Return to top

Results & Indicators


Expected Results


The expected intermediate results for this project include: (1) increased detection of polio cases and response to common communicable diseases; (2) increased and sustained immunity of target groups against wild polio transmission in all districts of the twelve highest risk states; and (3) increased protection of Nigerians with routine immunization against common preventable diseases, including polio.

Achieved Results


Results achieved as of the end of the project (March 2015) include: (1) Nigeria has made tremendous progress towards the interruption of wild poliovirus during this past year; (2) the percentage of 0-59 month-old children reached by oral polio vaccine (OPV) during supplemental immunization activities (SIAs) has increased from 81% in January 2014 to 96% by February 2015; (3) Global Affairs Canada contributed, along with other development partners, in reaching 6,226,104 children (about 91% of the target population) with polio vaccination in 12 states. This in turn has contributed to the reduction of the number of wild polio virus cases reported in Nigeria from 37 cases in 2013-2014 to five cases in 2014-15; (4) improving results from Lot Quality Assurance Sampling (LQAS) processes was demonstrated. Following the completion of the Immunization Plus Days (IPDs), the LQAS demonstrated that Nigeria’s quality assurance targets were exceeded in every IPD since January 2014; and (5) through ongoing data analysis in the Emergency Operations Centres (state and national), the program has developed strategic plans to address the identified challenges that prevent children from receiving oral polio vaccine (OPV).

Canada has played a unique role in the coordination of the donor group for polio, which assists in ensuring policy coherence and the communication of program and funding issues.

Indicators


  • None Selected
Return to top
Return to top

Associated Projects (If applicable)


Return to top
Icon